Top of page
Health

New drug may protect against memory loss in Alzheimer

Senior man taking medicine

A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics may protect against memory loss, nerve damage and other symptoms of Alzheimer’s disease.

Preclinical research found that the drug—called BPN14770—deters the effects of amyloid beta, a hallmark protein of Alzheimer’s that is toxic to nerve cells.

Recent studies find Alzheimer’s may develop without dementia in nearly 25% of healthy 80-year-old patients, suggesting the body may turn to compensatory mechanisms to maintain the nervous system.

BPN14770, under development by Tetra Therapeutics, could help activate these mechanisms that support nerve health and prevent dementia, even with the progression of Alzheimer’s.

Its benefits could also translate to Fragile X syndrome, developmental disabilities and schizophrenia, researchers say.

“Such observations imply that Alzheimer’s pathology can be tolerated by the brain to some extent due to compensatory mechanisms operating at the cellular and synaptic levels,” said Ying Xu, MD, Ph.D., co-lead investigator and research associate professor in the UB School of Pharmacy and Pharmaceutical Sciences.

“Our new research suggests that BPN14770 may be capable of activating multiple biological mechanisms that protect the brain from memory deficits, neuronal damage and biochemical impairments.”

The study, published on Sept. 5 in the Journal of Pharmacology and Experimental Therapeutics, was also led by James M. O’Donnell, Ph.D., dean and professor of the UB School of Pharmacy and Pharmaceutical Sciences. Mark E. Gurney, Ph.D., chairman and chief executive officer of Tetra Therapeutics, based in Grand Rapids, Michigan, collaborated on the research.

 

You might also like

Deaf patient use video conference, make online consultation by sign language with doctor on tablet Deaf patient use video conference, make online consultation by sign language with doctor on tablet

HHS and DOJ issue guidance on nondiscrimination in telehealth

The U.S. Department of Health and Human Services (HHS) and…

Woman silhouette with sun and clouds in her head Woman silhouette with sun and clouds in her head

Applications open for Diverse Communities Mental Health and Wellbeing Grants

Applications are now open for round two of the Diverse…

Close up of taking sample for coronavirus testing Close up of taking sample for coronavirus testing

Free RAT program for eligible Victorians with disability extended

The free rapid antigen tests program for eligible Victorians with…

The Yang-Tan Institute of Employment and Disability has joined a multi-institution team that has received a $5 million grant from the National Science Foundation (NSF) to help create better job outcomes for people with autism. The Yang-Tan Institute of Employment and Disability has joined a multi-institution team that has received a $5 million grant from the National Science Foundation (NSF) to help create better job outcomes for people with autism.

Research shows AI can improve stroke diagnostics

A new study presented on Thursday at the Society of…